Institutions Holding Call Options on Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the call option holders of Ultragenyx Pharmaceutical Inc. (RARE). We have compiled data on the institutions that hold call options on the stock, with a total of 505,300 call options outstanding, which have been reported (via 13F filing form) to have a value of $27.9 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Barclays PLC
London, X0 |
Aug 14, 2024 Q2 2024 |
174,000
calls
|
$9.47 Million
0.0% of portfolio
|
Q2 2024
Added 480.0%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 15, 2024 Q2 2024 |
165,500
calls
|
$9.01 Million
0.0% of portfolio
|
N/A
|
|
|
Moore Capital Management, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
100,000
calls
|
$5.44 Million
0.08% of portfolio
|
Q2 2024
Added 33.33%
|
|
|
Ubs Oconnor LLC
Chicago, IL |
Aug 14, 2024 Q2 2024 |
40,000
calls
|
$2.18 Million
0.1% of portfolio
|
Q2 2024
Added 273.83%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
23,400
calls
|
$1.27 Million
0.0% of portfolio
|
N/A
|
|
|
Walleye Capital LLC
Plymouth, MN |
Aug 14, 2024 Q2 2024 |
2,400
calls
|
$130,632
0.0% of portfolio
|
N/A
|